Search

Your search keyword '"M. Lario"' showing total 39 results

Search Constraints

Start Over You searched for: Author "M. Lario" Remove constraint Author: "M. Lario"
39 results on '"M. Lario"'

Search Results

1. Intestinal Immune Dysregulation Driven by Dysbiosis Promotes Barrier Disruption and Bacterial Translocation in Rats With Cirrhosis

2. 125P Benefit of immunotherapy in advanced NSCLC patients selected by KRAS mutations: A single institute retrospective analysis

3. 52P Genetic and clinical profiling of a cohort of extended small cell lung carcinoma

4. 6P Clinical and molecular characteristics in non-small cell lung cancer patients with alteration in PIK3 pathway

5. 218P Clinical characteristics and treatment outcomes in lung cancer patients with FGFR genes alterations

6. 124P KRAS mutated (mt) non-small cell lung cancer (NSCLC) and response to antiPD-1/PD-L1 regarding co-mutational status and assessment of KRAS mutation on plasma or tissue biopsy

7. Obeticholic acid reduces bacterial translocation and inhibits intestinal inflammation in cirrhotic rats

8. Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance

9. Defective thymopoiesis and poor peripheral homeostatic replenishment of T-helper cells cause T-cell lymphopenia in cirrhosis

10. Interaction between intestinal dendritic cells and bacteria translocated from the gut in rats with cirrhosis

11. Critical role of the liver in the induction of systemic inflammation in rats with preascitic cirrhosis

12. Intestinal inflammation worsens epithelial barrier function in rats with cirrhosis and ascites: role of commensal gut flora

13. A Multiscale Four-Dimensional Data Assimilation System Applied in the San Joaquin Valley during SARMAP. Part I: Modeling Design and Basic Performance Characteristics

14. APPLICATION OF AN ATMOSPHERIC SIMULATION MODEL TO DIAGNOSE AIR-POLLUTION TRANSPORT IN THE GRAND CANYON REGION OF ARIZONA

15. The biological response modifier AM3 attenuates the inflammatory cell response and hepatic fibrosis in rats with biliary cirrhosis

16. Systemic inflammation in absence of gut bacterial translocation in C57BL/6 mice with cirrhosis

17. Glutaminase-1 (GLS1) inhibition limits metastatic progression in osteosarcoma

18. O153 THE FARNESOID X RECEPTOR AGONIST, OBETICHOLIC ACID, IMPROVES INTESTINAL ANTIBACTERIAL DEFENSE AND REDUCES GUT BACTERIAL TRANSLOCATION AND HEPATIC FIBROGENESIS IN CCl4-CIRRHOTIC RATS WITH ASCITES

19. P29 COMMENSAL BACTERIA DRIVES THE EXPANSION OF PROINFLAMMATORY T-LYMPHOCYTES IN THE SMALL INTESTINAL MUCOSA AND WORSENS THE EPITHELIAL BARRIER FUNCTION IN CCl4 CIRRHOTIC RATS WITH ASCITIS

20. 500 THE BIOLOGICAL RESPONSE MODIFIER AM3 ATTENUATES THE LIVER AND PERIPHERAL BLOOD INFLAMMATORY IMMUNE SYSTEM ACTIVATION AND REDUCES HEPATIC FIBROSIS IN RATS WITH BILIARY CIRRHOSIS

23. 609 SMALL INTESTINE INFLAMMATION IN RATS WITH CCL4 CIRRHOSIS: ROLE OF ENTERIC BACTERIA

24. Etymological curiosities or words are the key to the world

25. 528 THE DEFECTIVE FUNCTION OF GUT DENDRITIC CELLS OF RATS WITH CIRRHOSIS AND BACTERIAL TRANSLOCATION IS CORRECTED BY BOWEL DECONTAMINATION WITH ANTIBIOTICS

27. Comments on 'Truncation Errors in Finite-Difference Estimates of Geostrophic Wind and Relative Vorticity'

28. Sensitivity of Mesoscale‐Model Forecast Skill to Some Initial‐Data Characteristics, Data Density, Data Position, Analysis Procedure and Measurement Error

29. Spanish language, an indispensable tool of Russian companies oriented abroad: how to meet the demand?

31. Intestinal Immune Dysregulation Driven by Dysbiosis Promotes Barrier Disruption and Bacterial Translocation in Rats With Cirrhosis.

32. Obeticholic acid reduces bacterial translocation and inhibits intestinal inflammation in cirrhotic rats.

33. Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance.

34. Defective thymopoiesis and poor peripheral homeostatic replenishment of T-helper cells cause T-cell lymphopenia in cirrhosis.

36. Interaction between intestinal dendritic cells and bacteria translocated from the gut in rats with cirrhosis.

37. Critical role of the liver in the induction of systemic inflammation in rats with preascitic cirrhosis.

38. The biological response modifier AM3 attenuates the inflammatory cell response and hepatic fibrosis in rats with biliary cirrhosis.

Catalog

Books, media, physical & digital resources